Showing 1 - 20 results of 34 for search '"Signal Transduction and Targeted Therapy"', query time: 0.05s Refine Results
  1. 1
    Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells

    Chimeric antigen receptor with novel intracellular modules improves antitumor performance of T cells by Pengju Wang, Yiyi Wang, Xiaojuan Zhao, Rui Zheng, Yiting Zhang, Ruotong Meng, Hao Dong, Sixin Liang, Xinyi He, Yang Song, Haichuan Su, Bo Yan, An-Gang Yang, Lintao Jia

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages

    Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages by Jingyun Yang, Xuemei He, Huashan Shi, Cai He, Hong Lei, Heng He, Li Yang, Wei Wang, Guobo Shen, Jinliang Yang, Zhiwei Zhao, Xiangrong Song, Zhenling Wang, Guangwen Lu, Jiong Li, Yuquan Wei

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

    A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 by Zhe Chen, Leilei Feng, Lei Wang, Li Zhang, Binyang Zheng, Hua Fu, Fengdi Li, Ligai Liu, Qi Lv, Ran Deng, YanLi Xu, Yongfeng Hu, Jianhua Zheng, Chuan Qin, Linlin Bao, Xiangxi Wang, Qi Jin

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis

    The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis by Kun Meng, Yuying Li, Xiaoyi Yuan, Hui-Min Shen, Li-Ling Hu, Danya Liu, Fujin Shi, Dandan Zheng, Xinyu Shi, Nengqiao Wen, Yun Cao, Yun-Long Pan, Qing-Yu He, Chris Zhiyi Zhang

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Mitochondrial heterogeneity: subpopulations with distinct metabolic activities

    Mitochondrial heterogeneity: subpopulations with distinct metabolic activities by Fabian den Brave, Swadha Mishra, Thomas Becker

    Published 2025-02-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial

    Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial by Guoshuang Shen, Zhilin Liu, Miaozhou Wang, Yi Zhao, Xinlan Liu, Yujin Hou, Wenbiao Ma, Jingqi Han, Xiaofeng Zhou, Dengfeng Ren, Fuxing Zhao, Zitao Li, Shifen Huang, Yongzhi Chen, Yingjian He, Yan Liu, Zijun Zhu, Yongxin Li, Jinming Li, Mengting Da, Hongnan Mo, Feng Du, Liang Cui, Jing Bai, Zhen Liu, Fei Ma, Jiuda Zhao

    Published 2025-02-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Preclinical CSF proteomic changes: a milestone in biomarker detection for autosomal dominant Alzheimer’s disease

    Preclinical CSF proteomic changes: a milestone in biomarker detection for autosomal dominant Alzheimer’s disease by J. Alexander Ross, Richard Dodel

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Artificial intelligence propels lung cancer screening: innovations and the challenges of explainability and reproducibility

    Artificial intelligence propels lung cancer screening: innovations and the challenges of explainability and reproducibility by Mario Mascalchi, Chiara Marzi, Stefano Diciotti

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells

    Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells by Gui-Qi Zhu, Zheng Tang, Tian-Hao Chu, Biao Wang, Shi-Ping Chen, Chen-Yang Tao, Jia-Liang Cai, Rui Yang, Wei-Feng Qu, Yi Wang, Qian-Fu Zhao, Run Huang, Meng-Xin Tian, Yuan Fang, Jun Gao, Xiao-Ling Wu, Jian Zhou, Wei-Ren Liu, Zhi Dai, Ying-Hong Shi, Jia Fan

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Tissue-resident immune cells: from defining characteristics to roles in diseases

    Tissue-resident immune cells: from defining characteristics to roles in diseases by Jia Li, Chu Xiao, Chunxiang Li, Jie He

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study

    Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study by Haiyu Wang, Guangying Cui, Ming Cheng, Tuerganaili Aji, Guotao Li, Xinjun Hu, Guangming Li, Shixi Zhang, Yanyang Zhang, Linqi Diao, Pan Li, Ling Wang, Yiqiang Yuan, Guowu Qian, Ruiqing Zhang, Xiaoli Jin, Juan Wang, Hong Luo, Donghua Zhang, Mingming Wang, Silin Li, Zhan Song, Mengzhao Yang, Guanyue Su, Ranran Sun, Junbiao Chang, Zujiang Yu, Zhigang Ren

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial

    Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial by Marion Thibaudin, Nicolas Roussot, Chloé Burlot, Antonin Schmitt, Julie Vincent, Zoé Tharin, Leila Bengrine, Hélène Bellio, Aurélie Bertaut, Léa Hampe, Susy Daumoine, Emilie Rederstorff, Morgane Peroz, Titouan Huppe, Valentin Derangère, David Rageot, John Simard, Caroline Truntzer, Jean David Fumet, Francois Ghiringhelli

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use

    Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use by Yu Zhang, Ke Qiu, Jianjun Ren, Yu Zhao, Ping Cheng

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial

    Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial by Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, Yong-Ming Chen, Yuan-Fang Li, Cheng-Cai Liang, Mu-Yan Cai, Guo-Ming Chen, Wei Wang, Xiao-Wei Sun, De-Sheng Weng, Dan-Dan Li, Jing-Jing Zhao, Xiao-Jiang Chen, Yuan-Xiang Guan, Zhi-Min Liu, Yao Liang, Ma Luo, Jun Chi, Hai-Bo Qiu, Zhi-Wei Zhou, Xiao-Shi Zhang, Ying-Bo Chen

    Published 2025-02-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Proteins lead the way: JAK inhibitors as a new treatment option in toxic epidermal necrolysis

    Proteins lead the way: JAK inhibitors as a new treatment option in toxic epidermal necrolysis by Benjamin Klein, J. Michelle Kahlenberg, Johann E. Gudjonsson

    Published 2025-02-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Immunotherapy in ovarian cancer: spatial functional genomics to unravel resistance mechanisms

    Immunotherapy in ovarian cancer: spatial functional genomics to unravel resistance mechanisms by Martina Rausch, Karlotta Bartels, Josef Leibold

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study

    Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, resp... by Fei Wang, Yongjiu Wang, Bin Xiong, Zhenlin Yang, Jingfen Wang, Yumin Yao, Lixiang Yu, Qinye Fu, Liang Li, Qiang Zhang, Chao Zheng, Shuya Huang, Liyuan Liu, Chun Liu, Huaibo Sun, Beibei Mao, Dong-Xu Liu, Zhigang Yu

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Digestive cancers: mechanisms, therapeutics and management

    Digestive cancers: mechanisms, therapeutics and management by Tianzuo Zhan, Johannes Betge, Nadine Schulte, Lena Dreikhausen, Michael Hirth, Moying Li, Philip Weidner, Antonia Leipertz, Andreas Teufel, Matthias P. Ebert

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer

    A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive... by Zhiwei Chen, Jianhua Chen, Dingzhi Huang, Wei Zhang, Lin Wu, Tienan Yi, Qiming Wang, Liang Han, Liping Tan, Yinyin Li, Zhihong Zhang, Na Li, Jie li, Tongmei Zhang, Ying Hu, Hongmei Sun, Youhua Wu, Zhiyong He, Runxiang Yang, Peng Cheng, Xingya Li, Jianhua Shi, Guohua Yu, Daiyuan Ma, Benjamin Xiaoyi Li, Xiangrong Dai, Michael Wong, Yujie Li, Xiaohui Yu, Shun Lu, for the Socazolimab Study Group

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Beyond incretins: targeting neurokinin receptors for obesity treatment

    Beyond incretins: targeting neurokinin receptors for obesity treatment by Doreen Thor, Simone Prömel

    Published 2025-01-01
    “…Signal Transduction and Targeted Therapy…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: